Home Companies Aktis Oncology, Inc. COMPANY
FDA-cleared device company Clinical Phase 1
1 open job · last seen Oct 23, 2026 · 2 sources
Keywords: oncology prostate cancer Urothelial Carcinoma Bladder Triple Negative Breast Cancer Hormone Receptor Positive Breast Adenocarcinoma Non Small Cell Lung Cancer Cervical Adenocarcinoma Colorectal Adenocarcinoma Head and Neck Cancer Castration Resistant Metastatic Prostate Cancer mCRPC (Metastatic Castration-resistant Prostate Cancer) mCRPC B7H3 [225Ac]Ac-AKY-1189 (therapeutic) [225Ac]Ac-AKY-2519 (therapeutic) Show all 15 keywords
Location: Boston, MA · source · Oct 12, 2026
Profile checked Oct 10, 2026
At a glance HQ Boston, MA source Stage FDA-cleared device company Clinical Phase 1 Latest trial Phase 1: A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer (Jun 17, 2026) source Timeline Jun 17, 2026 Trial start Phase 1: A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer source ↗ Aug 22, 2025 Trial start Phase 1: A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors source ↗ Upcoming milestones 2027-12 (ESTIMATED) · Phase 1 · A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors · NCT07020117 2027-12 (ESTIMATED) · Phase 1 · A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer · NCT07581184 Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2 Record Title Phase Status Start Primary completion NCT07020117 A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors Phase 1 Recruiting Aug 22, 2025 2027-12 (estimated) NCT07581184 A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer Phase 1 Recruiting Jun 17, 2026 2027-12 (estimated)
Raises and investors new Form D raises come from the company’s own SEC filing (last 2 years).
Investor Listed in the portfolio of MPM BioImpact (captured Oct 12, 2026). portfolio page ↗ Open jobs 1 Title Location (from posting, not HQ) Employer posted First seen Level Senior Clinical Trial Manager Boston, MA, US Jun 3, 2026 Oct 11, 2026 Senior Description
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Connect See your connections at Aktis Oncology on LinkedIn (search by name, results not checked) LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-18
